Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Self-regulating AAV vectors for safe expression of MeCP2 in rett syndrome

Self-regulating AAV vectors for safe expression of MeCP2 in rett syndrome

US Patent 11680275 · Granted Jun 20, 2023

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Bicistronic AAV vectors encoding hexosaminidase alpha and beta-subunits and uses2025
rAAV vectors for the treatment of GM1 and GM2 gangliosidosis2025
AAV-mediated gene therapy for maple syrup urine disease (MSUD)2025
AAV-mediated gene therapy for maple syrup urine disease (MSUD)2025
Minigene therapy2025
Modified AAV constructs and uses thereof2025
Viral vector production2025
Heterologous targeting peptide grafted AAVs2025
Inhibition of protein kinases to treat Friedreich ataxia2025
Cyclic dinucleotide prodrug molecule, preparation method therefor and applicatio2025
Gene therapeutics for treating bone disorders2025
Gene therapeutics for treating bone disorders2025